Health Central is a 171-bed hospital in Ocoee, Florida. In April 2012, Orlando Health acquired Health Central for $181.3 million.

There are 171 beds in Orlando Health.

During the past decade, Orlando Health conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 1 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Orlando Health" #1 collaborator was "AstraZeneca" with 2 trials as a collaborator, "German Breast Group" with 1 trials as a collaborator, "NSABP Foundation Inc" with 1 trials as a collaborator and "Spanish Breast Cancer Research Group (SOLTI)" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Orlando Health" are "HER2-Positive Primary Breast Cancer" (1 trials), "Metastatic Breast Cancer" (1 trials) and "Residual Invasive Breast Cancer" (1 trials). Many other conditions were trialed in "Orlando Health" in a lesser frequency.

Most popular intervention types in "Orlando Health" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "DS-8201a" (1 trials), "Fulvestrant" (1 trials), "Palbociclib" (1 trials), "Placebo" (1 trials) and "T-DM1" (1 trials). Other intervention names were less common.

The vast majority of trials in "Orlando Health" are 1 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Orlando Health". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Orlando Health, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Orlando Health, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".